GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Osaka Exchange Adopts Nasdaq’s Eqlipse Technology for Next-Generation Derivatives Platform

by GOAI
Share To

Japan’s Osaka Exchange has implemented Nasdaq’s Eqlipse trading and surveillance technology as part of its next-generation derivatives platform. The adoption aims to enhance the exchange’s trading infrastructure and improve market surveillance capabilities. This move marks a significant step in modernizing the Osaka Exchange’s systems to meet evolving market demands.

The new technology integrates advanced trading functionalities with enhanced monitoring tools, designed to ensure efficient and secure operations for derivatives trading. Nasdaq’s Eqlipse platform provides scalability and flexibility, enabling the Osaka Exchange to adapt to future technological advancements and regulatory requirements. This collaboration reflects ongoing efforts by exchanges worldwide to adopt cutting-edge solutions that support market integrity and operational efficiency.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top